Rare
lephants
Screener
Toggle theme
Cellectis S.A.
CLLS
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2024
FY2015
Total Cash from Operations:
$112.1M
Line Item
Value
% of Total
Capital Expenditures
$2.6M
2.3%
Other Investing
$100.2M
89.4%
Net Cash Flow
$9.3M
8.3%
Download CSV
